Upcoming Shows & Events

American Association of Cancer Research (AACR)

Check out our activities from the conference, and learn more about our new products below.


Apr 15, 2018 - Apr 18, 2018

9:00 AM - 5:00 PM
LOCATION: McCormick Place
Chicago, IL

Spotlight Theater

Powering Precision Oncology Research: Developing gene expression signatures and high plex digital spatial profiling technology

A special thank you to our speakers:

Speakers: David Rimm, MD, Ph.D. | Yale University School of Medicine, Karen Leroy | Universite Paris Descartes & Joseph Beechem, Ph.D. | NanoString Technologies 

New Product Introductions

Accelerate your signature development! New IO360™ & Breast Cancer 360™ Gene Expression Panels provide a unique 360 degree view of tumor, mircoenvironment and immune response.

Digital Spatial Profiling Instrument Reveal

Revealed to the public for the first time! Access the DSP profiling capability through our TAP program here. 

Grant Programs

AACR Exclusive Digital Spatial Profiling (DSP) Insta-Grant winner: Robyn Gartrell, Columbia University Medical Center

Gene Expression Pathway Grant

Apply today and expedite your pathway analysis and generate publication quality data with our new sample multiplexing reagents (96 mRNA genes X 96 samples). Five winners will receive NanoString PlexSet™ Reagent Panels for their research. Deadline is May 31, 2018!

Poster Presentations

Comprehensive Immune and Molecular Analysis of Two Metastatic Melanoma Patients Treated with a Personal Neoantigen Vaccine, NEO-PV-01, in Combination with Anti-PD-1: A Case Study

High-plex immune marker spatial profiling quantitation by NanoString® Digital Spatial Profiling technology and quantitative immunofluorescence 

Validation of Digital Spatial Profiling of Key Immuno-Oncology Targets for Mouse FFPE Preclinical Models

Digital spatial profiling platform allows for spatially-resolved, high-plex quantification of mRNA distribution and abundance on FFPE and fresh frozen tissue sections

Highly multiplexed analysis of immune cell subsets in non-small cell lung cancer: validation of protein and RNA analysis by the NanoString DSP platform

The Tumor Inflammation Signature (TIS) is predictive of anti-PD1 treatment benefit in the CERTIM pan-cancer cohort

Prognostic Gene Signature use in checkpoint inhibitor mono-therapy for melanoma

Simple and rapid high-plex analysis of RNA and protein from low frequency sorted T cells

Digital gene expression of up to 96 targets in 96 samples for cell line screening with nCounter® PlexSet